Tag:

ovarian cancer biomarker

Latest Headlines

Latest Headlines

Researchers zero in on biomarker for early diagnosis of ovarian cancer

Investigators say that a biomarker in the blood--carbohydrate antigen 125, or CA125--offers a shot at a relatively low-cost approach to identifying ovarian cancer  at an early stage, while the chances of survival are much higher.

Researchers zero in on biomarker for early diagnosis of ovarian cancer

Investigators say that a biomarker in the blood--carbohydrate antigen 125, or CA125--offers a shot at a relatively low-cost approach to identifying ovarian cancer  at an early stage, while the chances of survival are much higher.

Stem cell factor could improve ovarian cancer prognosis

In a recent study, researchers at Yale School of Medicine have identified a key link between stem cell factors that fuel ovarian cancer's growth and patient prognosis.

Stem cell factor could improve ovarian cancer prognosis

In a recent study, researchers at Yale School of Medicine have identified a key link between stem cell factors that fuel ovarian cancer's growth and patient prognosis.

BRCA mutations may pinpoint response to Abbott's veliparib

BRCA1 and BRCA2 mutations are already used as biomarkers to point out those people at increased risk of breast and ovarian cancer, but they could also pinpoint the women most likely to respond to Abbott's investigational cancer drug, veliparib.

BRCA mutations may pinpoint response to Abbott's veliparib

BRCA1 and BRCA2 mutations are already used as biomarkers to point out those people at increased risk of breast and ovarian cancer, but they could also pinpoint the women most likely to respond to Abbott's investigational cancer drug, veliparib.

Study validates gene variant in ovarian cancer

KRAS is a known cancer-causing gene, linked with lung, pancreatic and colorectal cancer, as well as leukemia. A study published in PLoS One has also linked a variant of the gene with ovarian and breast cancer, finding it in almost half of women with both cancers. It could have potential as a biomarker.

Study validates gene variant in ovarian cancer

KRAS is a known cancer-causing gene, linked with lung, pancreatic and colorectal cancer, as well as leukemia. A study published in PLoS One has also linked a variant of the gene with ovarian and breast cancer, finding it in almost half of women with both cancers. It could have potential as a biomarker.

Scoring genes in ovarian cancer could predict treatment response

Researchers from the Dana-Farber Cancer Institute have created a score based on the expression of genes involved in the repair of DNA after platinum-based treatment to see if this could predict the response, but the take on this is mixed.

Scoring genes in ovarian cancer could predict treatment response

Researchers from the Dana-Farber Cancer Institute have created a score based on the expression of genes involved in the repair of DNA after platinum-based treatment to see if this could predict the response, but the take on this is mixed.